Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Response to Duret et al.

Pastori D, Baratta F, Ernesti I, Violi F, Angelico F, Del Ben M.

Am J Gastroenterol. 2018 May;113(5):775-776. doi: 10.1038/s41395-018-0055-2. Epub 2018 Apr 23. No abstract available.

PMID:
29681626
2.

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.

Di Costanzo A, Belardinilli F, Bailetti D, Sponziello M, D'Erasmo L, Polimeni L, Baratta F, Pastori D, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Giannini G, Del Ben M, Angelico F, Arca M.

Sci Rep. 2018 Feb 27;8(1):3702. doi: 10.1038/s41598-018-21939-0.

3.

Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome.

Baratta F, Pastori D, Bucci T, Fabiani M, Fabiani V, Brunori M, Loffredo L, Lillo R, Pannitteri G, Angelico F, Del Ben M.

Sleep Med. 2018 Mar;43:66-70. doi: 10.1016/j.sleep.2017.09.032. Epub 2018 Feb 8.

PMID:
29482815
4.

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.

Del Ben M, Overi D, Polimeni L, Carpino G, Labbadia G, Baratta F, Pastori D, Noce V, Gaudio E, Angelico F, Mancone C.

Int J Mol Sci. 2018 Feb 18;19(2). pii: E603. doi: 10.3390/ijms19020603.

5.

Severity of OSAS, CPAP and cardiovascular events: A follow-up study.

Baratta F, Pastori D, Fabiani M, Fabiani V, Ceci F, Lillo R, Lolli V, Brunori M, Pannitteri G, Cravotto E, De Vito C, Angelico F, Del Ben M.

Eur J Clin Invest. 2018 May;48(5):e12908. doi: 10.1111/eci.12908. Epub 2018 Mar 3.

PMID:
29424037
6.

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress.

Carpino G, Pastori D, Baratta F, Overi D, Labbadia G, Polimeni L, Di Costanzo A, Pannitteri G, Carnevale R, Del Ben M, Arca M, Violi F, Angelico F, Gaudio E.

Sci Rep. 2017 Nov 17;7(1):15756. doi: 10.1038/s41598-017-15943-z.

7.

Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Baratta F, Pastori D, Polimeni L, Bucci T, Ceci F, Calabrese C, Ernesti I, Pannitteri G, Violi F, Angelico F, Del Ben M.

Am J Gastroenterol. 2017 Dec;112(12):1832-1839. doi: 10.1038/ajg.2017.371. Epub 2017 Oct 24.

PMID:
29063908
8.

Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.

Polimeni L, Pastori D, Baratta F, Tozzi G, Novo M, Vicinanza R, Troisi G, Pannitteri G, Ceci F, Scardella L, Violi F, Angelico F, Del Ben M.

Intern Emerg Med. 2017 Dec;12(8):1159-1165. doi: 10.1007/s11739-017-1746-1. Epub 2017 Sep 12.

PMID:
28900817
9.

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.

Angelico F, Corradini SG, Pastori D, Fargion S, Fracanzani AL, Angelico M, Bolondi L, Tozzi G, Pujatti PL, Labbadia G, Corazza GR, Averna M, Perticone F, Croce G, Persico M, Bucci T, Baratta F, Polimeni L, Del Ben M, Violi F; LAL-Cirrhosis Collaborative Research Group.

Atherosclerosis. 2017 Jul;262:179-184. doi: 10.1016/j.atherosclerosis.2017.03.038. Epub 2017 Mar 31.

PMID:
28396038
10.

Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.

Di Costanzo A, D'Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, Loffredo L, Perri L, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Catalano C, Maranghi M, Del Ben M, Angelico F, Arca M.

Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21.

PMID:
28027788
11.

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.

Del Ben M, Polimeni L, Baratta F, Pastori D, Angelico F.

Br J Clin Pharmacol. 2017 Jan;83(1):88-95. doi: 10.1111/bcp.12899. Epub 2016 Mar 4. Review.

12.

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?

Baratta F, Pastori D, Polimeni L, Tozzi G, Violi F, Angelico F, Del Ben M.

Int J Mol Sci. 2015 Nov 25;16(12):28014-21. doi: 10.3390/ijms161226085. Review.

13.

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.

Pastori D, Baratta F, Carnevale R, Cangemi R, Del Ben M, Bucci T, Polimeni L, Labbadia G, Nocella C, Scardella L, Pani A, Pignatelli P, Violi F, Angelico F.

Clin Transl Gastroenterol. 2015 Oct 1;6:e113. doi: 10.1038/ctg.2015.43.

14.

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.

Baratta F, Pastori D, Del Ben M, Polimeni L, Labbadia G, Di Santo S, Piemonte F, Tozzi G, Violi F, Angelico F.

EBioMedicine. 2015 May 22;2(7):750-4. doi: 10.1016/j.ebiom.2015.05.018. eCollection 2015 Jul.

15.

Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study.

Pignatelli P, Pastori D, Perticone F, Corazza GR, Violi F; ARAPACIS (Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study) Study group.

Eur J Intern Med. 2015 Oct;26(8):e31-3. doi: 10.1016/j.ejim.2015.06.007. Epub 2015 Jun 27. No abstract available.

PMID:
26123820
16.

Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Polimeni L, Del Ben M, Baratta F, Perri L, Albanese F, Pastori D, Violi F, Angelico F.

World J Hepatol. 2015 Jun 8;7(10):1325-36. doi: 10.4254/wjh.v7.i10.1325. Review.

17.

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.

Violi F, Pastori D, Perticone F, Hiatt WR, Sciacqua A, Basili S, Proietti M, Corazza GR, Lip GY, Pignatelli P; ARAPACIS (Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study) STUDY group.

BMJ Open. 2015 May 21;5(5):e008026. doi: 10.1136/bmjopen-2015-008026.

18.

Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors.

Pastori D, Loffredo L, Perri L, Baratta F, Scardella L, Polimeni L, Pani A, Brancorsini M, Albanese F, Catasca E, Del Ben M, Violi F, Angelico F.

Am J Cardiol. 2015 May 15;115(10):1402-6. doi: 10.1016/j.amjcard.2015.02.032. Epub 2015 Feb 19.

PMID:
25776455
19.

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease.

Pastori D, Polimeni L, Baratta F, Pani A, Del Ben M, Angelico F.

Dig Liver Dis. 2015 Jan;47(1):4-11. doi: 10.1016/j.dld.2014.07.170. Epub 2014 Sep 16. Review.

20.

Modern approach to the clinical management of non-alcoholic fatty liver disease.

Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F.

World J Gastroenterol. 2014 Jul 14;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341. Review.

Supplemental Content

Loading ...
Support Center